Interferon alpha-n3: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 33: | Line 33: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 15:24, 17 March 2025
Interferon alpha-n3 is a type of interferon used in the treatment of certain medical conditions. It is a protein and antiviral agent produced by recombinant DNA technology.
Overview
Interferon alpha-n3 is a subtype of interferon alpha, a group of proteins and glycoproteins that are produced by the body's leukocytes and fibroblasts in response to viral infections, cancer, and other immune challenges. Interferon alpha-n3 is produced by recombinant DNA technology, which involves the insertion of a DNA sequence coding for the interferon into a suitable expression vector. The resulting product is a protein that is identical to the naturally occurring interferon alpha.
Medical Uses
Interferon alpha-n3 is used in the treatment of certain medical conditions, including hepatitis B and hepatitis C, Kaposi's sarcoma, and certain leukemias and lymphomas. It works by inhibiting viral replication and modulating the body's immune response.
Side Effects
Like all medications, interferon alpha-n3 can cause side effects. These may include flu-like symptoms, fatigue, depression, and anemia. In some cases, these side effects can be severe and may require medical attention.
See Also
References
<references />



